Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aliskiren versus ramipril versus combination therapy in decompensated chronic systolic heart failure
2008-001035-35Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of aliskiren, ramipril in heart failure with reduced ejection fraction (HFrEF), hypertension (HTN), sponsored by Novartis. Started Apr 2009; status: completed.
02
Drugs
aliskirenramipril
03
Conditions
heart failure with reduced ejection fraction (HFrEF)hypertension (HTN)
Beyond the preview
Go deeper on 2008-001035-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001035-35.